{"id":5608,"date":"2021-05-15T16:32:53","date_gmt":"2021-05-15T16:32:53","guid":{"rendered":"https:\/\/itsan.net\/?p=5608"},"modified":"2025-08-14T14:22:55","modified_gmt":"2025-08-14T14:22:55","slug":"alert-patient-focused-drug-development-meeting-september-23-2019","status":"publish","type":"post","link":"https:\/\/www.itsan.org\/us\/2021\/05\/15\/alert-patient-focused-drug-development-meeting-september-23-2019\/","title":{"rendered":"Alert: Patient-Focused Drug Development Meeting \u2013 September 23, 2019"},"content":{"rendered":"\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-av_one_full-15d750bd1b332b34c6e70b077ebbccdf\">\n.flex_column.av-av_one_full-15d750bd1b332b34c6e70b077ebbccdf{\nborder-radius:0px 0px 0px 0px;\npadding:0px 0px 0px 0px;\n}\n<\/style>\n<div  class='flex_column av-av_one_full-15d750bd1b332b34c6e70b077ebbccdf av_one_full  avia-builder-el-0  avia-builder-el-no-sibling  first flex_column_div av-zero-column-padding  '     ><section  class='av_textblock_section av-av_textblock-2de302bf1aa3cf4c9157dbe6f50ac7eb '   itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/BlogPosting\" itemprop=\"blogPost\" ><div class='avia_textblock'  itemprop=\"text\" ><h3 class=\"entry-title fusion-post-title\" data-fontsize=\"18\" data-lineheight=\"27\">Alert: Patient-Focused Drug Development Meeting \u2013 September 23, 2019<\/h3>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-5610\" src=\"https:\/\/itsan.net\/wp-content\/uploads\/2021\/05\/MTSD-announcing-800x419-1.gif\" alt=\"\" width=\"800\" height=\"419\" \/><\/p>\n<div>ITSAN is\u00a0so incredibly excited and proud to announce this very special event!\u00a0 For the past 8 months, we have been working tirelessly\u00a0together with\u00a0four nonprofit organizations serving the eczema community to launch \u201cMore Than Skin Deep\u201d \u2013 a series of opportunities for your perspective to inform and shape the understanding of eczema and the development of drugs and medical devices designed to treat this condition.<\/div>\n<div><\/div>\n<div>A focal point of the initiative is a patient-focused drug development (PFDD) meeting to be held September 23, 2019 in the Washington, D.C. area. It will provide the eczema community an opportunity to speak directly to Food and Drug Administration (FDA) staff, representatives of pharmaceutical and medical device companies, and other key stakeholders.<\/div>\n<div><\/div>\n<div>The PFDD series began in 2013 as a way for FDA and clinical trial sponsors to understand more fully the burdens of living with a particular medical condition, what patients most value in terms of treatment benefits, and what risks and side effects they are willing to tolerate.<\/div>\n<div><\/div>\n<div>The \u201cMore Than Skin Deep\u201d initiative is the first of its kind for eczema and we urge you to help make it as powerful as possible by contributing your perspective. A new website \u2013\u00a0<a href=\"http:\/\/www.morethanskindeep-eczema.com\">www.MoreThanSkinDeep-Eczema.com<\/a>\u00a0\u2013 is dedicated to empowering people living with eczema and their caregivers and care partners. It provides 3 ways for you to get involved:<\/div>\n<div>\n<ul>\n<li><strong>Complete the \u201cMore Than Skin Deep\u201d survey<\/strong>\u00a0\u2013 Your input will shape meeting discussion and will\u00a0be included in the report that follows the meeting.<\/li>\n<li>\n<p class=\"gmail-mc-toc-title\"><strong>Signal your interest in attending the September 23 meeting in person<\/strong>\u00a0\u2013 By registering and then\u00a0completing a brief questionnaire, you\u2019ll help us ensure that participants reflect the full range of\u00a0diverse experiences in the eczema community; travel support is available.<\/p>\n<\/li>\n<li>\n<p class=\"gmail-mc-toc-title\"><strong>RSVP to participate via live webcast on September 23<\/strong>\u00a0\u2013 You\u2019ll be part of the discussion via live\u00a0polling and \u201cchat\u201d features.<\/p>\n<\/li>\n<\/ul>\n<p>The collaboration among five organizations\u00a0to develop this initiative is itself a landmark event for the community and for PFDD; it is among the\u00a0<strong>largest<\/strong>\u00a0coalitions of organizations to partner for one of these meetings. An example of how PFDD can benefit people living with eczema is to deepen understanding about all the ways in which eczema impacts people\u2019s lives \u2013 beyond the discomfort of having red, itchy skin that is so often the sole focus and especially how regular \u201ceczema\u201d can take a turn for the worse to develop into RSS by the current standard of care.<\/p>\n<\/div>\n<div><strong>\u00a0<\/strong><\/div>\n<div>\n<p><strong>Please<\/strong>\u00a0consider participating in this landmark effort by visiting the new website and taking one or more of the requested actions. Your voice and perspectives are essential for us to demonstrate that eczema and is \u201cmore than skin deep.\u201d<\/p>\n<p class=\"gmail-mc-toc-title\"><strong>Let\u2019s DO this!!!<\/strong><\/p>\n<p>Kelly Barta, ITSAN President<\/p>\n<\/div>\n<\/div><\/section><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":5609,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"give_campaign_id":0,"footnotes":""},"categories":[25],"tags":[],"class_list":["post-5608","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/www.itsan.org\/us\/wp-json\/wp\/v2\/posts\/5608","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.itsan.org\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.itsan.org\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.itsan.org\/us\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.itsan.org\/us\/wp-json\/wp\/v2\/comments?post=5608"}],"version-history":[{"count":3,"href":"https:\/\/www.itsan.org\/us\/wp-json\/wp\/v2\/posts\/5608\/revisions"}],"predecessor-version":[{"id":9376,"href":"https:\/\/www.itsan.org\/us\/wp-json\/wp\/v2\/posts\/5608\/revisions\/9376"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.itsan.org\/us\/wp-json\/wp\/v2\/media\/5609"}],"wp:attachment":[{"href":"https:\/\/www.itsan.org\/us\/wp-json\/wp\/v2\/media?parent=5608"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.itsan.org\/us\/wp-json\/wp\/v2\/categories?post=5608"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.itsan.org\/us\/wp-json\/wp\/v2\/tags?post=5608"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}